Codexis Pharmaceuticals Cancels $100 Million IPO

Published: Sep 03, 2008

Codexis Inc., a Redwood City, Calif.-based provider of solutions for pharma chemical process development and manufacturing, has withdrawn registration for a $100 million IPO. It has planned to trade on the Nasdaq, with Credit Suisse and Goldman Sachs serving as co-lead underwriters. Codexis has raised just over $80 million in VC funding since 2002, from firms like CCTV Investments, CMEA Ventures, Pequot Capital, Bio*One Capital and Pfizer.

Back to news